Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions

Summary

Ischemic-type biliary lesions (ITBLs) are a major cause of graft loss and mortality after orthotopic liver transplantation (OLT). For now, there are still lacking effective treatment for ITBLs. The purpose of this study is to confirm whether human umbilical cord mesenchymal stem cells are effective in the treatment,or prevention of Ischemic-type Biliary Lesions after liver transplantation.

Timeline

Start

2014-07

Primary completion

2017-06

Completion

2018-06

Drugs

Indications